Smithkline Beecham Corporation

Nycomed Austria Gmbh

Other

Nycomed Imaging As

Hafslund Nycomed Pharma Aktiengesellschaft

Glaxosmithkline LLC

Johann Hiebl

Franz Rovenszky

Peter Kremminger

Michael Hartmann

Pradip Kumar Bhatnagar

Dirk Andries Heerding

James Francis Callahan

Alan Cuthbertson

Peter Fischer

Mette Husbyn

Hermann Kollmann

Ann Marie Eldridge

Jessie Sandosham

Ann M Eldridge

Processes for preparing N-methyl-L-alanine derivatives and novel intermediates of the process. The derivatives and intermediates are useful for preparing cell-binding agent/maytansinoid complexes.

Process and intermediates

Novel compounds of general formula (I) which have homoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.

Hemoregulatory compounds

The present invention relates to novel compounds which have hemoregulatory activities and can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.

The present invention relates to novel pyrazine compounds and their use in the regulation of haematopoiesis, in particular in the stimulation of haematopoiesis, and in the treatment of bacterial, viral and fungal diseases.

Pyrazinedicarboxylic-acid derivatives as cell proliferation regulators

Pyrazine fused to a cyclic peptide

The invention relates to a new process for the preparation of substituted diaminodicarboxylic acid derivatives of the formula ##STR1## in a high yield by a modified Kolbe synthesis.

Process for the preparation of substituted diamino-dicarboxylic acid

Growing community of inventors

Linz, Austria

Johann Hiebl